Skip to main content
Premium Trial:

Request an Annual Quote

Xceleron Extends Supplier Agreement with GlaxoSmithKline

NEW YORK, Oct. 24 (GenomeWeb News) GlaxoSmithKline has extended its supplier agreement with Xceleron for three years, Xceleron said today.


Xceleron, specializing in accelerator mass spectrometry (AMS) services, said that it will support GlaxoSmithKline's bioanalytical AMS program specifically for human metabolite profiling and obtaining mass balance data.


One of the organizations behind Xceleron's founding in 1997, GlaxoSmithKline has been a client since that time, Xceleron said.


Xceleron will also provide GSK with consulting services to develop AMS analytical processes, problem-solving, and back-up analysis.


Financial terms of the agreement were not disclosed.